Stefan Mihaela S, Pekow Penelope S, Shea Christopher M, Hughes Ashley M, Hill Nicholas S, Steingrub Jay S, Lindenauer Peter K
1Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School-Baystate, Springfield, MA USA.
2Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield, MA USA.
Implement Sci Commun. 2020;1(1):46. doi: 10.1186/s43058-020-00028-2. Epub 2020 May 6.
COPD is the fourth leading cause of death in the US, and COPD exacerbations result in approximately 700,000 hospitalizations annually. Patients with acute respiratory failure due to severe COPD exacerbation are treated with invasive (IMV) or noninvasive mechanical ventilation (NIV). Although IMV reverses hypercapnia/hypoxia, it causes significant morbidity and mortality. There is strong evidence that patients treated with NIV have better outcomes, and NIV is recommended as first line therapy in these patients. Yet, several studies have demonstrated substantial variation in the use of NIV across hospitals, leading to preventable morbidity and mortality. Through a series of mixed-methods studies, we have found that successful implementation of NIV requires physicians, respiratory therapists (RTs), and nurses to communicate and collaborate effectively, suggesting that efforts to increase the use of NIV in COPD need to account for the complex and interdisciplinary nature of NIV delivery and the need for team coordination. Therefore, we propose to compare two educational strategies: online education (OLE) and interprofessional education (IPE) which targets complex team-based care in NIV delivery.
Twenty hospitals with low baseline rates of NIV use will be randomized to either the OLE or IPE study arm. The primary outcome of the trial is change in the hospital rate of NIV use among patients with COPD requiring ventilatory support. In aim 1, we will compare the uptake change over time of NIV use among patients with COPD in hospitals enrolled in the two arms. In aim 2, we will explore mediators' role (respiratory therapist autonomy and team functionality) on the relationship between the implementation strategies and implementation effectiveness. Finally, in aim 3, through interviews with providers, we will assess acceptability and feasibility of the educational training.
This study will be among the first to carefully test the impact of IPE in the inpatient setting. This work promises to change practice by offering approaches to facilitate greater uptake of NIV and may generalize to other interventions directed to seriously-ill patients.
Name of registry: ClinicalTrials.govTrial registration number: NCT04206735Date of Registration: December 20, 2019.
慢性阻塞性肺疾病(COPD)是美国第四大死因,COPD急性加重每年导致约70万例住院治疗。因严重COPD急性加重导致急性呼吸衰竭的患者接受有创机械通气(IMV)或无创机械通气(NIV)治疗。虽然IMV可纠正高碳酸血症/低氧血症,但会导致显著的发病率和死亡率。有强有力的证据表明,接受NIV治疗的患者预后更好,NIV被推荐作为这些患者的一线治疗方法。然而,多项研究表明,不同医院在NIV的使用上存在很大差异,导致了可预防的发病率和死亡率。通过一系列混合方法研究,我们发现成功实施NIV需要医生、呼吸治疗师(RT)和护士进行有效的沟通与协作,这表明在COPD中增加NIV使用的努力需要考虑到NIV实施的复杂性和跨学科性质以及团队协调的必要性。因此,我们建议比较两种教育策略:在线教育(OLE)和针对NIV实施中基于团队的复杂护理的跨专业教育(IPE)。
20家NIV使用基线率较低的医院将被随机分为OLE或IPE研究组。该试验的主要结局是需要通气支持的COPD患者中NIV使用的医院发生率的变化。在目标1中,我们将比较两组入选医院中COPD患者NIV使用随时间的接受率变化。在目标2中,我们将探讨中介因素(呼吸治疗师的自主性和团队功能)在实施策略与实施效果之间关系中的作用。最后,在目标3中,通过对提供者的访谈,我们将评估教育培训的可接受性和可行性。
本研究将是首批在住院环境中仔细测试IPE影响的研究之一。这项工作有望通过提供促进NIV更多使用的方法来改变实践,并可能推广到针对重症患者的其他干预措施。
注册机构名称:ClinicalTrials.gov试验注册号:NCT04206735注册日期:2019年12月20日。